Page last updated: 2024-11-04

sulfaphenazole and Heart Failure

sulfaphenazole has been researched along with Heart Failure in 2 studies

Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.

Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heim, R1
Lucas, S1
Grombein, CM1
Ries, C1
Schewe, KE1
Negri, M1
Müller-Vieira, U1
Birk, B1
Hartmann, RW1
Fischer, D1
Landmesser, U1
Spiekermann, S1
Hilfiker-Kleiner, D1
Hospely, M1
Müller, M1
Busse, R1
Fleming, I1
Drexler, H1

Other Studies

2 other studies available for sulfaphenazole and Heart Failure

ArticleYear
Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity.
    Journal of medicinal chemistry, 2008, Aug-28, Volume: 51, Issue:16

    Topics: Animals; Cytochrome P-450 CYP11B2; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Fibr

2008
Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure.
    European journal of heart failure, 2007, Volume: 9, Issue:8

    Topics: Aged; Anti-Infective Agents; Arteries; Aryl Hydrocarbon Hydroxylases; Chronic Disease; Cytochrome P-

2007